Zobrazeno 1 - 10
of 49
pro vyhledávání: '"P.M Kicovic"'
Publikováno v:
Obstetrics & Gynecology. 92:574-579
Objective: To investigate the effects of tibolone on trabecular and cortical bone mineral density and on indices of calcium metabolism in postmenopausal women with previous fractures. Methods: In a 2-year, randomized, double-blind, placebo-controlled
Publikováno v:
Maturitas. 13(3)
Long-term therapy with (7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14; tibolone, Livial) has no influence on the endometrium in post-menopausal women. This was concluded from endometrial biopsies taken from 39 post-menopau
Publikováno v:
Maturitas. 13(3)
The cardiovascular effects of Org OD 14, a synthetic steroid which relieves climacteric symptoms without stimulating the endometrium, were assessed in a group of healthy post-menopausal women. Limb blood flow was measured by venous occlusion plethysm
Publikováno v:
Maturitas. 12(1)
The effects of 2.5 mg/day 7α, 17α-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14) on lipid metabolism, with particular reference to high-density lipoprotein (HDL)-related variables, were assessed in 14 healthy post-menopausal women
Publikováno v:
Contraception. 15:105-112
Five healthy female volunteers were given the “morning-after” injection intramuscularly 1–4 days after midcycle LH peak. The medication consisted of 12.5 mg of estradiol-benzoate and 10 mg of estradiol-phenylpropionate. In both control and trea
Autor:
P.M. Kicovic, J. Prisić
Publikováno v:
Contraception. 8:315-326
The use of a continuous low-dose of lynestrenol as an oral contraceptive has been investigated in a total of 274 women during 2702 cycles. A daily dose of 0.5 mg ** was found to give a satisfactory contraceptive protection; a total of two pregnancies
Publikováno v:
Maturitas. 2(4)
Seventy-four postmenopausal women presenting with vaginal atrophy were treated with either Ovestin® vaginal cream (Group A, 23 women: 1 mg/day E3; Group B, 30 women: 0.5 mg/day E3) or vaginal suppositories (Group C, 21 women: 0.5 mg/day E3), applied
Publikováno v:
Journal of Steroid Biochemistry. 11:xx
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.